−200KRW
−20.50 BKRW
90.08 BKRW
13.11 M
About BIONOTE
Sector
Industry
CEO
Byung-Ki Cho
Website
Headquarters
Hwaseong-si
Employees (FY)
366
Founded
2003
ISIN
KR7377740006
FIGI
BBG01B193KH7
BioNote, Inc. engages in the research, development, and manufacture of diagnostic testing products for animals. Its products include animal diagnostics and bio-contents. The company was founded on March 28, 2003 and is headquartered in Hwaseong-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 377740 is 3985.00 KRW — it has decreased by 2.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BIONOTE stocks are traded under the ticker 377740.
Yes, you can track BIONOTE financials in yearly and quarterly reports right on TradingView.
Like other stocks, 377740 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIONOTE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 366.00 employees. See our rating of the largest employees — is BIONOTE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIONOTE EBITDA is −38.96 B KRW, and current EBITDA margin is −43.25%. See more stats in BIONOTE financial statements.